FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2025
Back to search
Official data from USPTO
RONOMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RONOMA
ST13
US500000079373992Class
5, 35, 42, 44
Filing
79373992
Registration
7602065
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 35, 42, 44
Filing date
05/26/2023
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
KUHN, RIO NICE
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
C. U. (pessoa física)
Representatives
Robert J. Kenney Willcox & Savage, P.C.
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceuticals sold on prescriptionnamely those treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; chemical preparations for pharmaceutical or medical usenamely for diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous system; pharmaceutical preparations for combating the symptoms of Alzheimer's disease; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for all means of administrationnamely pharmaceutical preparations for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical solutionsgels and powders for all types of administration for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration; pharmaceutical solutionsgels and powders for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration
Class 35
Public relations; database management; establishing statistics in the nature of compilation of statistics for business or commercial purposes; sales promotions; organization of exhibitions for commercial and advertising purposes; organizingmanagingconducting exhibitionsfairs for advertising or commercial purposes; collection and systematization of data for business purposes in a central file in the field of pharmaceuticalhealth and medical research and development; retail store services or wholesale store services featuring pharmaceuticals productspharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous systempharmaceutical preparations for combating symptoms of Alzheimer's diseasepharmaceutical preparations for treating Alzheimer's diseasepharmaceutical solutionsgels and powders for all types of administration
Class 42
Medical research; biological research; scientific research for medical purposes in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; information with respect to medical and scientific research relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; providing laboratory research services in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; scientific research and development for medical purposes; scientific research in the field of chemistry; scientific research in the field of pharmacology; research and development of medicines; scientific research in the field of galenics; preclinical studies and research; clinical studies and research; consultancy with respect to pharmacology
Class 44
Medical services; medical services relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; treating symptoms relating to central nervous system diseases and neurodegenerative diseaseshealth care services for treating symptoms relating to central nervous diseases and neurodegenerative diseases; treating diseases of the central nervous system and neurodegenerative diseaseshealth care services for treating diseases of the central nervous system and neurodegenerative diseases; treating Alzheimer's disease and its symptomshealth care services for treating Alzheimer's disease and its symptoms; medical information services; providing medical information; providing information in the field of diagnosing and treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer'svia a website
Publications
History of USPTO decisions and trademark events.
25 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/23/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
05/23/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/15/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2024
RFNT
REFUSAL PROCESSED BY IB
04/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/15/2024
RFRR
REFUSAL PROCESSED BY MPU
03/14/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/23/2024
CNRT
NON-FINAL ACTION WRITTEN
02/22/2024
DOCK
ASSIGNED TO EXAMINER
02/20/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/14/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/13/2023
Continuous trademark protection
Get notified about every new filing that threatens RONOMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.